Skip to main content
logo
Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
10.62
-0.36 (-3.28%)
At close: Dec 22, 2025, 4:00 PM EST
10.62
0.00 (0.00%)
After-hours: Dec 22, 2025, 5:39 PM EST

Entrada Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Market Capitalization
381612503424534-
Upgrade
Market Cap Growth
-46.11%21.70%18.72%-20.71%--
Upgrade
Enterprise Value
103224219236610-
Upgrade
Last Close Price
10.9817.2915.0913.5217.12-
Upgrade
PE Ratio
-9.33----
Upgrade
PS Ratio
7.352.903.90---
Upgrade
PB Ratio
1.161.432.081.991.79-
Upgrade
P/TBV Ratio
1.111.432.081.991.79-
Upgrade
P/FCF Ratio
--3.75---
Upgrade
P/OCF Ratio
--3.60---
Upgrade
EV/Sales Ratio
1.681.061.69---
Upgrade
EV/EBITDA Ratio
-4.41----
Upgrade
EV/EBIT Ratio
-4.77----
Upgrade
EV/FCF Ratio
--1.63---
Upgrade
Debt / Equity Ratio
0.150.140.280.12--
Upgrade
Debt / EBITDA Ratio
-0.924.68---
Upgrade
Debt / FCF Ratio
--0.51---
Upgrade
Asset Turnover
0.130.420.36---
Upgrade
Quick Ratio
13.7410.782.268.6243.3211.62
Upgrade
Current Ratio
14.0811.152.339.5544.4611.89
Upgrade
Return on Equity (ROE)
-27.11%19.56%-2.94%-37.01%-30.19%-93.94%
Upgrade
Return on Assets (ROA)
-15.71%5.90%-0.55%-21.79%-18.29%-53.97%
Upgrade
Return on Capital (ROIC)
-17.33%7.36%-0.72%-22.63%-18.86%-59.03%
Upgrade
Return on Capital Employed (ROCE)
-31.30%9.70%-1.00%-42.30%-17.10%-66.40%
Upgrade
Earnings Yield
-27.40%10.72%-1.33%-22.33%-9.57%-
Upgrade
FCF Yield
-34.37%-7.30%26.68%-22.82%-10.38%-
Upgrade
Buyback Yield / Dilution
-15.95%-18.01%-5.62%-399.27%-467.09%-18.45%
Upgrade
Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q